Drugs / graft versus host disease prophylaxis/therapy
graft versus host disease prophylaxis/therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00361049 | Sep 2004 → Jun 2009 | cancer | Case Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | graft versus host disease prophylaxis/therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00361049 ↗ |
| Modality | Cell therapy | “patients undergo donor MSC infusion over 10-15 minutes.” NCT00361049 ↗ |